SlideShare a Scribd company logo
1 of 86
Drug risk assessment & Pharmacoepidemiology Rob Heerdink 23 April 2010
Dr Rob Heerdink Pharmacoepidemiology & Pharmacotherapy Utrecht Institute for Pharmaceutical Sciences Universiteit Utrecht The Netherlands www.pharm.uu.nl/epithera
Drug development discovery Discovery & screening Proof of Concept first administration to man registration & launch approx.  10-12 years 10,000 Pre-clinical development 15-30 Fase I/IIa 10-15 Fase IIb/III 1 5 preclinical clinical (I-III) phase IV
Science 2005; 307: 196-8.
Phase I to III research not very informative on safety ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
2 types of side effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
2 types of side effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pre-occupation with type B side effects  (“tabloids”) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Why do we know so little about side effects of drugs? ,[object Object],[object Object],[object Object],[object Object],[object Object]
A numbers game Clinical trials Market
Too  small ,[object Object],[object Object],[object Object],[object Object]
Sample size requirement in RCT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The likelihood of observing an adverse drug reaction employing numbers usually studied in premarketing trials Number of Patients Threshold for ADR Probability 2,000 1 / 500 0.98 (Lymphoma From Azathioprine)  1 / 1,000 0.86 (Eye Damage From Practolol)   1 / 10,000 0.18 (Anaphylaxis From Penicillin)   1 / 50,000 0.04  (Aplastic Anemia From Chloramphenicol)   Lembit Rägo, WHO Upsala
Too  short
 
Herald Tribune 30-09-96
“ It was easy money during the first trial, but that spinal tap really hurt.” Herald Tribune 30-09-96
Real patients ,[object Object]
Real patients ,[object Object],[object Object]
Real patients ,[object Object],[object Object],[object Object]
Real patients ,[object Object],[object Object],[object Object],[object Object],[object Object],geen 1 >1
Real patients ,[object Object],[object Object],[object Object],[object Object],[object Object]
Are Subjects in Pharmacological Treatment Trials of Depression Representative of Patients in Routine Clinical Practice? Mark Zimmerman, M.D.,  Jill I. Mattia, Ph.D., and  Michael A. Posternak, M.D Am J Psychiatry 159:469-473, March 2002 ‘ Of 346 patients with ‘major depression’ only 14% are eligible according to inclusioncriteria for trials with antidepressants’
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0 Risperidon (Janssen) 3  / 1 1  / 0
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0 Risperidon (Janssen) 3  / 1 1  / 0  Clozapine (Novartis) 1  / 0 1  / 0
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0 Risperidon (Janssen) 3  / 1 1  / 0  Clozapine (Novartis) 1  / 0 1  / 0 Ziprasidone (Pfizer) 1  / 1 Amisulpiride (Sanofi) 1  / 0
RCTs ,[object Object],[object Object]
RCTs ,[object Object],[object Object],[object Object],[object Object],[object Object]
evidence based medicine ?
pharmacoepidemiology medicine based evidence
 
Relevant questions in practice following registration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Evaluation of therapy: golden standard Randomised Controlled Clinical Trial (RCT) Randomise: why?  Controlgroup: why? Blinding: why? Goal: Only difference between treated and untreated  group is the treatment
Experiments are often impossible Ethical (e.g. smoking, birth defects) Practical (e.g. rare adverse effects) Non-experimental (observational) research For example: Do animals bite more often during full moon?
Do animals bite more during a full moon? Bhattacharjee C et al. BMJ 2000;321:1559-61
DOMAIN Determinant(s) Endpoint(s) time ,[object Object],[object Object],[object Object],Study design
Pharmacoepidemiological designs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Observational studies Past   Present    Future Retrospective Cohort Prospective Cohort Case-Control (retrospective) Cross-sectional
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Lancet, 1961
LETTER TO THE EDITOR THALIDOMIDE AND CONGENITAL ABNORMALITIES Sir, Congenital disorders are present in  approximately 1.5% of babies. In recent months  I have observed that the incidence of multiple  severe abnormalities in babies delivered of  women who were given the drug thalidomide  ('Distaval') during pregnancy,as an anti-emetic  or as a sedative, to be almost 20%. Have any of your readers seen similar  abnormalities in babies delivered of women  who have taken this drug during pregnancy? McBride WG. The Lancet, December 16, 1961: page 1358
Example  cross-sectional study Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication Gregoor et al  J Clin Psychopharmacol (in press) Research question:  are LEPR polymorphisms associated with increased BMI in antipsychotic users Study design:  cross-sectional
Example :  LEPR study Population: 200 patients using antipsychotics Determinants:  LEPR  Q223R and  LEP  promoter 2548G/A SNP polymorphisms Outcome: BMI
Example :  LEPR study ** p<0.05 N BMI>30 Males QQ 30 6 (20%) QR 73 16 (21%) RR 31 8 (26%) Females QQ 17 12 (71%) ** QR 39 15 (39%) QR 10 4 (40%)
Indexed prevalence and incidence per year of antidepressant use during 1992-2001 (1992=1).   Meijer et al.  Eur J Clin Pharmacol (2004) 60: 57–61
Observational Cohort ,[object Object]
 
Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
A cohort study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Merlo J, et al. BMJ 1996;313:457-61.
Another cohort study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Klungel et al. Epidemiology 2001;12:339-34 4.
Follow up study versus RCT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Follow-up studies more vulnerable to bias
Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
Case-control study Study Population Cases Controls Exposed Non-exposed Exposed Non-exposed
Example case-control study ,[object Object],[object Object],[object Object],[object Object]
Coogan et al. Am J Epidemiol 2005
Meijer et al. Arch Int Med 2004
Selection of cases ,[object Object],[object Object],[object Object],[object Object]
Selection of cases ,[object Object],[object Object],[object Object],[object Object]
Selection of Controls ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Selection of Controls ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Ascertainment of outcome and exposure status ,[object Object],[object Object],[object Object],[object Object]
Prospective vs. retrospective Cohort Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Selection of the Exposed Population ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Selection of the Comparison Population ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Data Collection External Data Sources Internal Data Sources Exposure Hospital records, employers Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Event Disease registries, death certificates, physician and hospital records  Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Confounder Hospital records registries Questionnaires, physical examinations
Bias ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Strengths in Cohort vs. Case-control? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Limitations in Cohort vs. Case-control? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Risk assessment
 
Registration of a drug is only the beginning of safety research
Practical exercise ,[object Object],[object Object]
N Engl J Med 2006;354:579-87
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
 
Practical exercise ,[object Object]
Practical exercise ,[object Object],[object Object],[object Object],[object Object]
Design ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Design ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Design ,[object Object],[object Object]

More Related Content

What's hot

Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Ahmad Ali
 
Pharm d research project
Pharm d research projectPharm d research project
Pharm d research projectSai Kumar
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Devguest41e570
 
Active and passive survillance
Active and passive survillanceActive and passive survillance
Active and passive survillanceRamavath Aruna
 
Introduction to Clinical trial
Introduction to Clinical trial Introduction to Clinical trial
Introduction to Clinical trial rx_sonali
 
Pharmacoepidemology by K bennett
Pharmacoepidemology by K bennettPharmacoepidemology by K bennett
Pharmacoepidemology by K bennettSuvarta Maru
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyGovind Girase
 
Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2RobHeerdink
 
Types of clinical studies
Types of clinical studiesTypes of clinical studies
Types of clinical studiesSamir Haffar
 
Clinical Trail and Pharmacovigilance
Clinical Trail and PharmacovigilanceClinical Trail and Pharmacovigilance
Clinical Trail and PharmacovigilanceRamavath Aruna
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyAsma Ashraf
 
Journal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug SafetyJournal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug SafetyOMICS International
 

What's hot (20)

Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
 
Pharm d research project
Pharm d research projectPharm d research project
Pharm d research project
 
Pharmacoepideiology
PharmacoepideiologyPharmacoepideiology
Pharmacoepideiology
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Dev
 
Clincal trails phases
Clincal trails  phasesClincal trails  phases
Clincal trails phases
 
Active and passive survillance
Active and passive survillanceActive and passive survillance
Active and passive survillance
 
Introduction to Clinical trial
Introduction to Clinical trial Introduction to Clinical trial
Introduction to Clinical trial
 
Pharmacoepidemology by K bennett
Pharmacoepidemology by K bennettPharmacoepidemology by K bennett
Pharmacoepidemology by K bennett
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Pharmacoepidemiology
Pharmacoepidemiology Pharmacoepidemiology
Pharmacoepidemiology
 
Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2
 
Types of clinical studies
Types of clinical studiesTypes of clinical studies
Types of clinical studies
 
Clinical Trail and Pharmacovigilance
Clinical Trail and PharmacovigilanceClinical Trail and Pharmacovigilance
Clinical Trail and Pharmacovigilance
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Clincial trials and types
Clincial trials and typesClincial trials and types
Clincial trials and types
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Journal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug SafetyJournal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug Safety
 

Similar to Drug Risk Assessment Studies

College 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoekCollege 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoekRobHeerdink
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Mina Max
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized MedicineMichel Dumontier
 
Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007Flavio Guzmán
 
Medical Literature
Medical Literature		Medical Literature
Medical Literature Khalid
 
DDI studies in humans
DDI studies in humans DDI studies in humans
DDI studies in humans GovindMishra61
 
Tapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin KrebsTapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin KrebsPaul Coelho, MD
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation Group Health Cooperative
 
Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)Chaithanya Malalur
 
WFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof GrunzeWFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof GrunzeJP Rajendran
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsmack2286
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsmack2286
 
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...European School of Oncology
 
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...European School of Oncology
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...Cytel USA
 
Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Joost Burger
 

Similar to Drug Risk Assessment Studies (20)

College 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoekCollege 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoek
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
 
New pattern clinical study
New pattern clinical studyNew pattern clinical study
New pattern clinical study
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
 
Tribestan 2015
Tribestan 2015Tribestan 2015
Tribestan 2015
 
Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007
 
Medical Literature
Medical Literature		Medical Literature
Medical Literature
 
DDI studies in humans
DDI studies in humans DDI studies in humans
DDI studies in humans
 
Nocebo In FMS
Nocebo In FMSNocebo In FMS
Nocebo In FMS
 
Tapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin KrebsTapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin Krebs
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation
 
Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)
 
WFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof GrunzeWFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof Grunze
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medications
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medications
 
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
 
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
 
Ldn2020 pw
Ldn2020 pwLdn2020 pw
Ldn2020 pw
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
 
Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)
 

More from RobHeerdink

College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011RobHeerdink
 
Adherence in elderly
Adherence in elderlyAdherence in elderly
Adherence in elderlyRobHeerdink
 
Workshop kuopio 2010
Workshop kuopio 2010Workshop kuopio 2010
Workshop kuopio 2010RobHeerdink
 
AHC 26 Januari 2010
AHC 26 Januari 2010AHC 26 Januari 2010
AHC 26 Januari 2010RobHeerdink
 
Psychofarmaca In De Dagelijkse Praktijk Evidence Based
Psychofarmaca In De Dagelijkse Praktijk   Evidence BasedPsychofarmaca In De Dagelijkse Praktijk   Evidence Based
Psychofarmaca In De Dagelijkse Praktijk Evidence BasedRobHeerdink
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met AntidepressivaRobHeerdink
 

More from RobHeerdink (6)

College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011
 
Adherence in elderly
Adherence in elderlyAdherence in elderly
Adherence in elderly
 
Workshop kuopio 2010
Workshop kuopio 2010Workshop kuopio 2010
Workshop kuopio 2010
 
AHC 26 Januari 2010
AHC 26 Januari 2010AHC 26 Januari 2010
AHC 26 Januari 2010
 
Psychofarmaca In De Dagelijkse Praktijk Evidence Based
Psychofarmaca In De Dagelijkse Praktijk   Evidence BasedPsychofarmaca In De Dagelijkse Praktijk   Evidence Based
Psychofarmaca In De Dagelijkse Praktijk Evidence Based
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met Antidepressiva
 

Recently uploaded

Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...aartirawatdelhi
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...Taniya Sharma
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...narwatsonia7
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiLow Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiSuhani Kapoor
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Servicemakika9823
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...indiancallgirl4rent
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...narwatsonia7
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...astropune
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
 
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Dipal Arora
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsGfnyt
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 

Recently uploaded (20)

Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
 
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiLow Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 

Drug Risk Assessment Studies

  • 1. Drug risk assessment & Pharmacoepidemiology Rob Heerdink 23 April 2010
  • 2. Dr Rob Heerdink Pharmacoepidemiology & Pharmacotherapy Utrecht Institute for Pharmaceutical Sciences Universiteit Utrecht The Netherlands www.pharm.uu.nl/epithera
  • 3. Drug development discovery Discovery & screening Proof of Concept first administration to man registration & launch approx. 10-12 years 10,000 Pre-clinical development 15-30 Fase I/IIa 10-15 Fase IIb/III 1 5 preclinical clinical (I-III) phase IV
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. A numbers game Clinical trials Market
  • 11.
  • 12.
  • 13. The likelihood of observing an adverse drug reaction employing numbers usually studied in premarketing trials Number of Patients Threshold for ADR Probability 2,000 1 / 500 0.98 (Lymphoma From Azathioprine) 1 / 1,000 0.86 (Eye Damage From Practolol) 1 / 10,000 0.18 (Anaphylaxis From Penicillin) 1 / 50,000 0.04 (Aplastic Anemia From Chloramphenicol) Lembit Rägo, WHO Upsala
  • 15.  
  • 17. “ It was easy money during the first trial, but that spinal tap really hurt.” Herald Tribune 30-09-96
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23. Are Subjects in Pharmacological Treatment Trials of Depression Representative of Patients in Routine Clinical Practice? Mark Zimmerman, M.D., Jill I. Mattia, Ph.D., and Michael A. Posternak, M.D Am J Psychiatry 159:469-473, March 2002 ‘ Of 346 patients with ‘major depression’ only 14% are eligible according to inclusioncriteria for trials with antidepressants’
  • 24. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0
  • 25. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0 Risperidon (Janssen) 3 / 1 1 / 0
  • 26. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0 Risperidon (Janssen) 3 / 1 1 / 0 Clozapine (Novartis) 1 / 0 1 / 0
  • 27. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0 Risperidon (Janssen) 3 / 1 1 / 0 Clozapine (Novartis) 1 / 0 1 / 0 Ziprasidone (Pfizer) 1 / 1 Amisulpiride (Sanofi) 1 / 0
  • 28.
  • 29.
  • 32.  
  • 33.
  • 34. Evaluation of therapy: golden standard Randomised Controlled Clinical Trial (RCT) Randomise: why? Controlgroup: why? Blinding: why? Goal: Only difference between treated and untreated group is the treatment
  • 35. Experiments are often impossible Ethical (e.g. smoking, birth defects) Practical (e.g. rare adverse effects) Non-experimental (observational) research For example: Do animals bite more often during full moon?
  • 36. Do animals bite more during a full moon? Bhattacharjee C et al. BMJ 2000;321:1559-61
  • 37.
  • 38.
  • 39. Observational studies Past Present Future Retrospective Cohort Prospective Cohort Case-Control (retrospective) Cross-sectional
  • 40.
  • 42. LETTER TO THE EDITOR THALIDOMIDE AND CONGENITAL ABNORMALITIES Sir, Congenital disorders are present in approximately 1.5% of babies. In recent months I have observed that the incidence of multiple severe abnormalities in babies delivered of women who were given the drug thalidomide ('Distaval') during pregnancy,as an anti-emetic or as a sedative, to be almost 20%. Have any of your readers seen similar abnormalities in babies delivered of women who have taken this drug during pregnancy? McBride WG. The Lancet, December 16, 1961: page 1358
  • 43. Example cross-sectional study Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication Gregoor et al J Clin Psychopharmacol (in press) Research question: are LEPR polymorphisms associated with increased BMI in antipsychotic users Study design: cross-sectional
  • 44. Example : LEPR study Population: 200 patients using antipsychotics Determinants: LEPR Q223R and LEP promoter 2548G/A SNP polymorphisms Outcome: BMI
  • 45. Example : LEPR study ** p<0.05 N BMI>30 Males QQ 30 6 (20%) QR 73 16 (21%) RR 31 8 (26%) Females QQ 17 12 (71%) ** QR 39 15 (39%) QR 10 4 (40%)
  • 46. Indexed prevalence and incidence per year of antidepressant use during 1992-2001 (1992=1). Meijer et al. Eur J Clin Pharmacol (2004) 60: 57–61
  • 47.
  • 48.  
  • 49. Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
  • 50.
  • 51.
  • 52.
  • 53. Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
  • 54. Case-control study Study Population Cases Controls Exposed Non-exposed Exposed Non-exposed
  • 55.
  • 56. Coogan et al. Am J Epidemiol 2005
  • 57. Meijer et al. Arch Int Med 2004
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66. Data Collection External Data Sources Internal Data Sources Exposure Hospital records, employers Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Event Disease registries, death certificates, physician and hospital records Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Confounder Hospital records registries Questionnaires, physical examinations
  • 67.
  • 68.
  • 69.
  • 71.  
  • 72. Registration of a drug is only the beginning of safety research
  • 73.
  • 74. N Engl J Med 2006;354:579-87
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.  
  • 80.  
  • 81.  
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.

Editor's Notes

  1. Scok door de wereld Rozen ook doornen Final trigger betekende echter niet het einde
  2. A cohort study is a study where a group of individuals are followed. The study population is defined on basis on the presence or absence of exposure to a suspected risk factor for a disease. The cohort studies is either classified as a prospective or a retrospective study. The definition is based on the time of occurrence of the disease according to the initiation of the study. In the prospective studies the disease of interest is never occurred at initiation, the exposure are either presence at the beginning of the study or it can occur later. The prospective cohort you have to follow over time. In the retrospective cohort study, all the relevant events disease and exposure have occurred before the initiation of the study. outcome follow- up retrospective/prospective Protocol: study objectives, design choices, performance goals, monitoring and analysis procedures Manual of procedures/log book Centralised training of key personnel
  3. A cohort study is a study where a group of individuals are followed. The study population is defined on basis on the presence or absence of exposure to a suspected risk factor for a disease. The cohort studies is either classified as a prospective or a retrospective study. The definition is based on the time of occurrence of the disease according to the initiation of the study. In the prospective studies the disease of interest is never occurred at initiation, the exposure are either presence at the beginning of the study or it can occur later. The prospective cohort you have to follow over time. In the retrospective cohort study, all the relevant events disease and exposure have occurred before the initiation of the study. outcome follow- up retrospective/prospective Protocol: study objectives, design choices, performance goals, monitoring and analysis procedures Manual of procedures/log book Centralised training of key personnel
  4. Population based: All subjects with the disease in the study base or a random sample
  5. Start med side 137 H&amp;B Controls should be a part of the study base, not represent the entire non diseased population but the population of individuals who would have been identified and included as cases had they also developed the disease. Principles of Control selection Study base: Controls can be used to characterise the distribution of exposure Comparable-accuracy Equal reliability in the information obtained from cases and controls  no differential misclassification Deconfounding Elimination of confounding through control selection  matching or stratified sampling Those principles should not be regarded as absolute, but rather as points to consider in choosing a control group
  6. About interviews se side 143 H&amp;B,
  7. The prospective study is time consuming and therefore expensive on the other hand it is possible to have valid information on exposure, because it isn.t